Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-02-22 @ 7:05 AM
Study NCT ID:
NCT00426257
Status:
COMPLETED
Last Update Posted:
2018-08-24
First Post:
2007-01-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer
Sponsor:
The Netherlands Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
M06OVH-OVHIPEC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None